Status:
COMPLETED
A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Solution And A Varenicline Patch Applied To The Skin
Lead Sponsor:
Pfizer
Conditions:
Smoking Cessation
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
To evaluate the absorption, safety, and tolerability of a varenicline solution and a varenicline patch applied to the skin.
Detailed Description
Additional Study Purpose Details: Evaluation of the pharmacokinetic profile of a varenicline solution and a varenicline patch applied to the skin
Eligibility Criteria
Inclusion
- healthy, adult, male smokers
Exclusion
- significant medical illness
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00774605
Start Date
December 1 2008
End Date
December 1 2008
Last Update
January 26 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511